A mouse Sertoli cell line expressing anti-Mullerian hormone and its type II receptor

Molecular and Cellular Endocrinology

Volumn 136, Issue 1, 1998, Pages 57-65

  Dutertre, Martin ^a   Rey, Rodolfo ^a   Porteu, Arlette ^b   Josso, Nathalie ^a   Picard, Jean Yves ^a  

^a U Rech Sur l'Endocrinol D Ecl Normale Sup Dept Biol 1 R ^*  (France)

^b INSTITUT COCHIN   (France)

Author keywords

Anti Mullerian hormone; Anti Mullerian hormone receptor; Mullerian inhibiting substance; Sertoli cell line; Targeted oncogenesis; Testis tumour

Indexed keywords

HORMONE RECEPTOR; MESSENGER RNA; MUELLERIAN INHIBITING FACTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL LINE; CLONE; CONTROLLED STUDY; HORMONE ACTION; MOUSE; MUELLERIAN DUCT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SERTOLI CELL; TESTIS;

EID: 0344222221     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00214-1     Document Type: Article

References (47)

1. Alarid E.T., Windle J.J., Whyte D.B., Mellon P.L. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development. 122:1996;3319-3329.
2. Al-Attar L., Noël K., Dutertre M. et al. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J. Clin. Invest. 100:1997;1335-1343.
3. Baarends W.M., van Helmond M.J.L., Post M. et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. Development. 120:1994;189-197.
4. Baarends W.M., Hoogerbrugge J.W., Post M. et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Endocrinology. 136:1995;5614-5622.
5. Capel B., Hawkins J.R., Hirst E., Kioussis D., Lovell-Badge R. Establishment and characterization of conditionally immortalized cells from the mouse urogenital ridge. J. Cell. Sci. 109:1996;899-909.
6. Cate R.L., Mattaliano R.J., Hession C. et al. Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 45:1986;685-698.
7. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
8. Choi Y.W., Lee I.C., Ross S.R. Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice. Mol. Cell. Biol. 8:1988;3382-3390.
9. Collard M.W., Sylvester S.R., Tsuruta J.K., Griswold M.D. Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator. Biochemistry. 27:1988;4557-4564.
10. Cory S., Adams J.M. Transgenic mice and oncogenesis. Annu. Rev. Immunol. 6:1988;25-48.
11. Courjault-Gautier F., Antoine B., Bens M. et al. Activity and inducibility of drug-metabolizing enzymes immortalized hepatocyte-like cells (mhPKT) derived from a L-PK/Tag1 transgenic mouse. Exp. Cell. Res. 234:1997;362-372.
12. di Clemente N., Wilson C.A., Faure E. et al. Cloning, expression and alternative splicing of the receptor for anti-Müllerian hormone. Mol. Endocrinol. 8:1994;1006-1020.
13. Dupont E., Zhao H.F., Rhéaume E., Simard J., Luu-The V., Labrie F., Pelletier G. Localization of 3-beta-hydroxysteroid dehydrogenase/delta5-delta4-isomerase in rat gonads and adrenal glands by immunocytochemistry and in situ hybridization. Endocrinology. 127:1990;1394-1403.
14. Giuili G., Shen W.H., Ingraham H.A. The nuclear receptor SF-1 mediates sexually dimorphic expression of Müllerian Inhibiting Substance, in vivo. Development. 124:1997;1799-1807.
15. Gondos B., Berndston W. Postnatal and pubertal development. Russell L.D., Griswold M.D. The Sertoli Cell. 1993;115-154 Cache River Press, Clearwater, FL.
16. Guerrier D., Boussin L., Mader S., Josso N., Kahn A., Picard J.Y. Expression of the gene for anti-Müllerian hormone. J. Reprod. Fertil. 88:1990;695-706.
17. Hagenas L., Ritzèn E.M., Ploen L., Hansson V., French F.S., Nayfeh S. Sertoli cell origin of testicular androgen binding protein. Mol. Cell. Endocrinol. 2:1975;339-350.
18. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:1985;115-122.
19. Hatano O., Takayama K., Imai T., Waterman M.R., Takakusu A., Omura T., Morohashi K. Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development. 120:1994;2787-2797.
20. Imbeaud S., Carré-Eusèbe D., Rey R., Belville C., Josso N., Picard J.Y. Molecular genetics of the persistent Müllerian duct syndrome: a study of 19 families. Hum. Mol. Genet. 3:1994;125-131.
21. Imbeaud S., Faure E., Lamarre I. et al. Insensitivity to anti-Müllerian hormone due to a spontaneous mutation in the human anti-Müllerian hormone receptor. Nat. Genet. 11:1995;382-388.
22. Josso N., Legeai L., Forest M.G., Chaussain J.L., Brauner R. An enzyme-linked immunoassay for anti-Müllerian hormone: a new tool for the evaluation of testicular function in infants and children. J. Clin. Endocrinol. Metab. 70:1990;23-27.
23. Josso N., Cate R.L., Picard J.Y. et al. Anti Müllerian hormone, the Jost factor. Bardin C.W. Recent Progress in Hormone Research. 1993;1-59 Academic Press, San Diego.
24. Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Progr. Horm. Res. 8:1953;379-418.
25. Kananen K., Markkula M., Rainio E., Su J.G.J., Hsueh A.J.W., Huhtaniemi I.T. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/Simian virus T-antigen fusion gene: Characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol. Endocrinol. 9:1995;616-627.
26. Kluin P.M., Kramer M.F., de Rooij D.G. Proliferation of spermatogonia and Sertoli cells in maturing mice. Anat. Embryol. 169:1984;73-78.
27. La Quaglia M., Shima H., Hudson P., Takahashi M., Donahoe P.K. Sertoli cell production of Müllerian inhibiting substance in vitro. J. Urol. 136:1986;219-224.
28. Linder C.C., Heckert L.L., Goetz T.L., Griswold M.D. Follicle-stimulating hormone receptor gene promoter activity. Endocrine. 2:1994;957-966.
29. Magre S., Jost A. The initial phases of testicular organogenesis in the rat. An electron microscopy study. Arch. Anat. Microsc. Morphol. Exp. 69:1980;297-318.
30. Massagué J. TGF beta signaling: Receptors, transducers, and Mad proteins. Cell. 85:1996;947-950.
31. Mellon S.H., Miller W.L., Bair S.R., Moore C.C.D., Vigne J.L., Weiner R.I. Steroidogenic adrenocortical cell lines produced by genetically targeted tumorigenesis in transgenic mice. Mol. Endocrinol. 8:1994;97-108.
32. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway. Genes Dev. 10:1996;2577-2587.
33. Moore A., Krummen L.A., Mather J.P. Inhibins, activins, their binding proteins and receptors-interactions underlying paracrine activity in the testis. Mol. Cell. Endocrinol. 100:1994;81-86.
34. Morales C., Hugly S., Griswold M.D. Stage-dependent levels of specific mRNA transcripts in Sertoli cells. Biol. Reprod. 36:1987;1035-1046.
35. Münsterberg A., Lovell-Badge R. Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sex differentiation. Development. 113:1991;613-624.
36. Parker K.L., Schimmer B.P. The roles of the nuclear receptor steroidogenic factor 1 in endocrine differentiation and development. Trends Endocrinol. Metab. 7:1996;203-207.
37. Pelletier J., Schalling M., Buckler A.J., Rogers A., Haber D.A., Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5:1991;1345-1356.
38. Peschon J.J., Behringer R.R., Cate R.L., Harwood K.A., Idzerda R.L., Brinster R.L., Palmiter R.D. Directed expression of an oncogene to Sertoli cells in transgenic mice using Müllerian inhibiting substance regulatory sequences. Mol. Endocrinol. 6:1992;1403-1411.
39. Rossi P., Albanesi C., Grimaldi P., Geremia R. Expression of the mRNA for the ligand of c-kit in mouse Sertoli cells. Biochem. Biophys. Res. Comm. 176:1991;910-914.
40. Shen W.H., Moore C.C.D., Ikeda Y., Parker K.L., Ingraham H.A. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: A link to the sex determination cascade. Cell. 77:1994;651-661.
41. Sleigh M.J., Topp W.C., Hanich R., Sambrook J.F. Mutants of SV 40 with an altered small t protein are reduced in their ability to transform cells. Cell. 14:1978;79-88.
42. Steinberger A., Jakubowiak A. Sertoli cell culture: historical perspective and review of methods. Russell L.D., Griswold M.D. The Sertoli Cell. 1993;155-179 Cache River Press, Clearwater, FL.
43. Teixeira J., He W.W., Shah P.C. et al. Developmental expression of a candidate Müllerian inhibiting substance type II receptor. Endocrinology. 137:1996;160-165.
44. Vigier B., Picard J.Y., Campargue J., Forest M.G., Heyman Y., Josso N. Secretion of anti-Müllerian hormone by immature bovine Sertoli cells in primary culture, studied by a competition type radio-immunoassay: lack of modulation by either FSH or testosterone. Mol. Cell. Endocrinol. 43:1985;141-150.
45. Volckaert G., Feuntun J., Crawford L.V., Berg P., Fiers W. Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40. J. Virol. 30:1979;674-682.
46. Voutilainen R., Miller W.L. Human Müllerian inhibitory factor messenger ribonucleic acid is hormonally regulated in the fetal testis and in adult granulosa cells. Mol. Endocrinol. 1:1987;604-608.
47. Young S., Gooneratne S., Straus F.H., Zeller W.P., Bulun S.E., Rosenthal I.M. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome. Am. J. Surg. Pathol. 19:1995;50-58.